Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

At today’s ordinary Shareholders’ Meeting of HBM Healthcare Investments Ltd the shareholders approved all proposals submitted by the Board of Directors.

The Chairman of the Board of Directors Hans Peter Hasler and the existing board members Dr Rudolf Lanz, Mario G. Giuliani,  Dr Stella X. Xu and Dr Elaine V. Jones were re-elected for a further one year term. The existing members of the Compensation Committee Mario G. Giuliani, Dr Stella X. Xu and Dr Elaine E. Jones were also re-elected for a further one year term.  Furthermore, the shareholders approved the proposed compensation to the Board of Directors and to the Management.

In addition to the reduction in share capital through the cancellation of 220,000 registered treasury shares acquired as part of the share buyback programme, the Shareholders’ Meeting also approved a par value repayment of CHF 2.60 per share and a dividend of CHF 4.90 per share. The cash payment to shareholders will be made on 4 July 2025. The registered shares with entitlement to the distributions will be traded for the last time on 1 July 2025 (from 2 July 2025 without, ex-date).

The shareholders also approved a new share buyback programme over the next three years for a maximum of 10% of the outstanding shares for the purpose of cancellation through a capital reduction.

The presentation shown at the Shareholder’s Meeting 2025 can be accessed on the company's website at hbmhealthcare.com/en/investors/shareholders-meeting.